Marapharm Ventures Inc. reports on production of sun-grown cannabis facilities in Washington State
Canada NewsWire
KELOWNA, BC, Aug. 2, 2018
KELOWNA, BC, Aug. 2, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") reported on May 29, 2018 that the Company had closed and acquired operational assets, land and water rights related to two licensed cannabis producers operating in Tonasket, Washington.
The 21-acre site is home to 2 Washington State Liquor Control Board (WSLCB) approved commercial cannabis gardens. They operate under independent Tier 2 and Tier 3, I-502 Outdoor Producer Licenses. The Tier 2 garden is approved for 10,000 sq ft of canopy, the Tier 3 garden is approved for 30,000 sq ft of canopy.
The strains planted are: Green Ribbon, Toxic Green, Kimbo Kush, Purple Diesel, Cookie Puss, Cookie Monster, Blue Dream, Dr Who, Girl Scout Cookie, Gorilla Glue, Gelato, Ogre, Rosaberry, Dutch Treat, Blood Orange, Pineapple Kush, White LSD, GOD, Permafrost, Short Bread and Mendo Purps
Drone footage and new images will be available at www.marapharm.com under Washington Projects on August 6th, 2018.
Each license and garden must follow the stringent rules set forth by I-502 such as; security, fencing, traceability, employee qualifications and training, destruction of waste, transportation of product, testing, in-depth operation description, products used and soils.
Leading the team of both gardens, is Ian Dykstra, a passionate grower with extensive experience in cannabis cultivation. Ian manages the day-to-day operations of both gardens to ensure maximum efficiency, productivity and quality of the 40,000 sq ft canopy. Working closely with Ian are a team of seasoned cannaculturists.
Ian reports in the last week of May the team planted both gardens, with a culmination of 22 hybrid strains. The Tier 2 garden was planted with 2,160 plants, the Tier 3 garden was planted with 4,860 plants. The 7,020 plants are vibrant, healthy and varying in heights. "The season began with brisk temperatures, but June and July have seen ideal growing conditions with daily averages of 86F and lows of 53F, and the extended forecast looks great. During the next 6 to 8 weeks we will see significant growth."
The initiation to flower using light deprivation is currently underway. Light deprivation, aka light dep, is the process of forcing plants to flower with sunlight in a time of year that is not normally the flowering period of the sun's natural lighting cycle. Similar to controlling the light cycle with a grow light by turning it on and off with a timer, farmers can control the budding cycle by blocking the sunlight, making the plants think it's time to flower. Ian just recently won "Best Light Dep Flower - THC" at the first inaugural 2018 Sun Cup.
Working in synergy with Marapharm`s tenant, Alphapheno, the goal is to process the sun-grown cannabis product at the licenced facility located in Lynden, Washington.
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
SOCIAL MEDIA:
Facebook:
facebook.com/marapharm
Twitter: twitter.com/marapharm Web
STOCK EXCHANGES:
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm's ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD - LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward- looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.
 View original content with multimedia:http://www.prnewswire.com/news-releases/marapharm-ventures-inc-reports-on-production-of-sun-grown-cannabis-facilities-in-washington-state-300690880.html
SOURCE Marapharm Ventures Inc.
Marapharm Ventures Inc. Updates shareholders on market activity as Frankfurt's Clearstream announces closure of its doors to North American cannabis stocks
KELOWNA, BC, June 28, 2018 /PRNewswire/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") updates its shareholders on the recent announcement by Clearstream, a major central securities depository based in Frankfurt, Germany and comments on Company position.
On June 25, 2018, Clearstream Banking announced that they will only offer processing of receipt free of payment and against payment instructions from the local market until close of business on settlement date 29 June 2018. The Bridge will be closed from this date.
Clearstream Banking will continue to offer the services until close of business on settlement date 28 September 2018 after which they will no longer settle and safekeep securities where the main business is connected directly or indirectly to cannabis and other narcotics products. The company cited "legal reasons" for the change, and shared a list of 147 impacted securities, including many U.S. and Canadian companies such as Marapharm Ventures Inc., Aurora Cannabis Inc., Canopy Growth Corporation and GW Pharmaceuticals.
To read the full list of companies and news release visit: http://www.clearstream.com/clearstream-en/products-and-services/settlement/d18044/97742
Marapharm has always had a robust following of shareholders in Germany and has enjoyed visits from numerous shareholders to the Las Vegas site as well as the Head Office. The drone footage of the Las Vegas site, available on our website, was filmed and prepared for us by a shareholder visiting from Germany. It is with regret that Marapharm received this news. We understand that alternative options are being sought and we will keep shareholders informed as we get the opportunity to review these alternatives should they become available.
Since September 14, 2016, Marapharm Ventures Inc., has witnessed significant volume traded on three platforms (CSE, FSE, OTCQB/OTCXQ), totalling 259,291,099 shares. We strongly believe that the Company has been greatly affected in both the Canadian and US Markets ahead of the official news coming out of Germany as a sudden spike in trading has resulted in excess of 45 million shares being traded in as little as 30 days alone. During this 21-month period the Company has reinforced its strong position of progress through growth and expansion of its asset portfolio, enabling us to be revenue producing in 2018.
"Unfortunately, what we are witnessing, at least in the very short term, is a major clearing firm has put all of its related German investors on notice to settle their holdings of any cannabis related stock and rather aggressively at that. Just how far reaching this one particular clearing house is, is not yet known, but it appears substantial enough to create a buying opportunity at these levels." Corey Klassen, VP of Corporate Development.
It is with confidence that the Company provides a summarized update on its projects.
Nevada: The facilities were inspected by the City and a few minor changes were required before they will issue the occupancy permit. Workers are performing these corrections and installations on site. On receiving the occupancy permit and final state walk through cultivation can be transferred to these buildings. New drone footage can be viewed at www.marapharm.com
California: The Company received Conditional Use Permit approval for changes made to the design of its second cultivation center in Desert Hot Springs. This brings the first cultivation facility to the final engineering stage and the second facility to the start of engineering design. The dispensary in Desert Hot Springs has tripled revenues in its first three months.
Washington: The building is ready for it's interior improvements. Site preparation has been completed allowing for the completion of planting.
Canada: The Company entered into an LOI with Full Spectrum Medicinals with a view to transferring the late stage application on to property owned by FSM in the Salmon Arm area in British Columbia.
Maragold products: The CBD-infused natural oil skin care line went on to shelves at the dispensary in Desert Hot Springs.
"The evolution to access medical and recreational cannabis legally has created global challenges on all business and governmental platforms. We continue to face industry challenges together and are confident that all of our shareholders, and future investors will ultimately have their choice of international financial institutions all over the world". Linda Sampson, CEO
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm Ventures Inc. Reports The Mandatory Testing of The Environmental Control Equipment Is Complete And A Success
KELOWNA, BC, June 5, 2018 /PRNewswire/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company) reports that the mandatory 72-hour testing of its environmental control equipment in Las Vegas, Nevada, as reported in a news release on May 24, 2018, has been completed successfully.
Troy Rippe, Sr. Technical Advisor of Surna Inc., managed the 72-hour test working seamlessly with our electricians, water technicians and staff to ensure all of the mechanical environmental control equipment passed, meeting all of our unique design specifications. Testing and verification included: Start-up of the specialty propane fired chillers ensuring they operate at proper head pressure ranges to deliver the proper temperature to the building.
Balancing of pumps to water pressure and gallon per minute to ensure the delivery of the proper capacity to the indoor equipment.
Verification of the ductless fan coil units correct locations and determining the proper flow and water temperature to each of these, enabling the regulation and control of temperature and humidity to our specifications.
Concluding the test was the final inspections of all electrical connections, equipment mounting, controls and system wiring to assure that all work has been completed to meet the requirements for the final Building Code Inspection.
Marapharm's onsite personnel has completed their training and are impressed with the versatility of the equipment, which allows regulation of temperature and humidity, thereby creating state-of-the-art energy efficient grow climates, ultimately reducing cost to the facility.
"We are very proud to announce the successful start-up and commissioning of this very unique mechanical system utilizing chilled water systems that are almost completely disconnected from the electrical grid. While having enough electrical infrastructure is almost always a challenge in the design phase of projects, forward thinking companies like Marapharm are not only meeting that challenge but turning it into an advantage for themselves by investing into new technology that reduces ongoing operational energy costs." Troy Rippe, SURNA LEED AP, Sr. Technical Advisor, System Engineering and Product Development
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production or dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
SOCIAL MEDIA:
Facebook: facebook.com/marapharm
Twitter: twitter.com/marapharm
Web Program: marapharm.tv
STOCK EXCHANGES:
Marapharm Ventures Inc. Updates Shareholders on Remaining Inspections in Las Vegas, Nevada
Canada NewsWire
KELOWNA, BC, May 24, 2018
KELOWNA, BC, May 24, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") the Company advises shareholders on the scheduled timeline of the remaining final inspections of its Las Vegas, Nevada facilities.
On May 30th, the commissioning and 72-hour mandatory testing of our environmental control equipment will be performed. Water technicians, electricians and the Surna specialists are required to be on standby for collaboration at the site, synchronizing systems while the lights are "burned-in". This calibrated inspection process determines the necessary adjustments of the equipment to perfect the regulation of temperature and humidity, thereby creating state-of-the-art environmental climates. During this time, Marapharm staff will undergo training on the operation of the equipment to optimize energy efficiency.
On June 1st, the State of Nevada, Department of Taxation is scheduled to perform their follow-up final compliance inspections on both facilities. This incorporates a review of security processes, standard operating procedures (SOP's) state regulated inventory control and seed to sale systems. The Company is currently in compliance with these state requirements in our temporary buildings.
On June 4th, the City of North Las Vegas Building Department, the North Las Vegas Fire Department and the Public Works Department will perform their final inspections to "sign-off" on the Certificates of Occupancy, permitting us to transfer our genetics to the new cultivation facilities.
"It was only one year ago that there were no permanent buildings or utilities on our site and our team was rushing to complete the temporary buildings. This was necessary to meet all state and city regulatory requirements to facilitate our recreational licences, which were approved last May, 2017.
Much has been accomplished! I am so grateful for the hard work and adaptability of our team, contractors, and the continued encouragement of our shareholder support in this constantly evolving industry". Linda Sampson, CEO.
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Marapharm Ventures Inc. Closes Oversubscribed Financing for $4.5 million
Canada NewsWire
KELOWNA, BC, May 21, 2018
KELOWNA, BC, May 21, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") is pleased to announce that the non-brokered private placement unit offering announced in a news release on May 17, 2018, for gross proceeds of $4,000,000 has closed oversubscribed for total gross proceeds of $4,500,000.
The non-brokered private placement of 7,500,000 Units ("Units") at CDN $0.60 per Unit (the "Unit Offering"), the Unit consists of one common share of the Company (a "Common Share") and one-half of one common share purchase warrant of the Company (each whole warrant, a "Warrant"). Each warrant entitles the holder thereof to purchase one Common Share of the Company at an exercise price of $0.70 for a period of 12 months from the date of issuance of the warrant.
Pursuant to the terms of the warrants, the expiry date of the warrants may be accelerated should the closing price at which the common shares trade exceeds $0.85 for five consecutive trading days. Any warrants which remain unexercised after the accelerated expiry date will be cancelled.
The net proceeds raised from the Unit Offering are intended to be used for (i) further development of the Company's Las Vegas project (ii) further development of the Company's project in Washington State (iii) further development of the Company's projects in California and general corporate purposes. The common shares and warrants issued pursuant to the non-brokered offering are subject to a four month hold period. No finder's fees will be paid in connection with this non-brokered offering.
"We are weeks away from entering production at our newly built facilities in Nevada. 2018 will be the first revenue producing year for the Company, we are passionate about our future and excited to achieve these significant milestones," Linda Sampson, CEO.
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
SOCIAL MEDIA:
Facebook: facebook.com/marapharm
Twitter: twitter.com/marapharm
Web Program: marapharm.tv
STOCK EXCHANGES:
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm's ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD - LOOKING STATEMENTS:
Marapharm Ventures Inc. - U.S. Marijuana Reform Bill Historical First!
Canada NewsWire
KELOWNA, BC, May 16, 2018
KELOWNA, BC, May 16, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) '("Marapharm" or the "Company") is delighted to keep its shareholder's updated with U.S. cannabis reform. A U.S. House Committee has approved the first marijuana reform bill ever to be given a vote, until now, making this an historical event.
While legalization supporters have previously scored victories in the form of amendments attached to larger legislation, none of their standalone bills have ever advanced before.
Tim Walz and Chairman Phil Roe, M.D. introduced H.R. 5520, the VA Medicinal Cannabis Research Act of 2018, to authorize the Department of Veterans Affairs (VA) to advance scientific and medical research into the safety and efficacy of medicinal cannabis usage by veterans with diagnoses such as post-traumatic stress disorder (PTSD) and chronic pain. Upon introduction, the legislation was cosponsored by 28 Democrats and 7 Republicans.
https://democrats-veterans.house.gov/news/press-releases/veterans-and-research-groups-endorse-bipartisan-va-medicinal-cannabis-research
In a new poll by The American Legion, one in five veterans self-reported using marijuana to alleviate a medical or physical condition. 100% of respondents aged 18-30 support legalized medical cannabis.
http://norml.org/images/_pdf/American_Legion_Poll_Nov_2_2017.pdf
Trending Election News
The U.S. midterm elections in Illinois, include eight Democrats vying for state attorney general. All of the candidates threw their support behind the full legalization of marijuana for recreational use, vowing to stymie any efforts by U.S. Attorney General Jeff Sessions to crack down on medical cannabis sales already being rung in across the state.
http://www.chicagotribune.com/suburbs/evanston/news/ct-evr-attorney-general-candidate-forum-tl-0118-20180117-story.html
In California, Sen. Dianne Feinstein, a long-time opponent of legalizing recreational marijuana, now says the federal government should not interfere in California's legal marijuana market. The California Democrat said she was open to considering federal protection for state-legalized marijuana.
http://www.mcclatchydc.com/news/politics government/congress/article210212224.html
Michigan Republicans consider legalizing cannabis prior to midterm elections. With enough signatures collected to get recreational marijuana on the ballot in the November mid-term election, it's looking like Michigan is set to join the ranks of legal states. As that reality begins to sink in for Republicans in the state's legislature, Michigan lawmakers are considering jumping the gun on the ballot initiative and legalizing before voters get a chance to.
https://herb.co/marijuana/news/michigan-republicans-cannabis-initiative-midterms
"Trump pollster: Candidates should embrace medical marijuana," by Robillard: "House and Senate candidates in competitive contests should embrace medical marijuana in their election bids this year, according to a new survey from the lead campaign pollster for now-President Donald Trump. A new nationwide poll from Tony Fabrizio, David Lee and Travis Tunis of Fabrizio, Lee and Associates found 77 percent of likely 2018 voters had a favorable opinion of medical marijuana, including 74 percent in key Senate states and 76 percent in competitive House districts. That total includes 68 percent of Republicans, 81 percent of independents and 84 percent of Democrats. Just 15 percent of likely voters have an unfavorable opinion of medical marijuana." https://www.politico.com/newsletters/morning-score/2018/03/19/the-biggest-republican-mega-donor-youve-never-heard-of-142121
Announced May 14, 2018, New York marijuana legalization effort is about to get a big boost. New York's Democratic Party is set to announce its full backing of marijuana legalization—news that broke on the same day that Gov. Andrew Cuomo (D) told reporters an official state study on the impacts of cannabis legalization that he ordered in January will be released "within days." https://www.marijuanamoment.net/new-york-marijuana-legalization-effort-about-to-get-a-big-boost/
"The Company has always remained confident that the legalization of cannabis for either medical or adult use is not just a proposed concept but rather a powerful movement of the people, fueled by the freedom of speech that social media invites. It is and will be a force that will have to be acknowledged." Linda Sampson, CEO.
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Marapharm Ventures Inc. - Appoints Lead Cultivators to Las Vegas Facilities in Nevada
Canada NewsWire
KELOWNA, BC, May 11, 2018
KELOWNA, BC, May 11, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") is pleased to announce the appointment of Mr. Ryan George and Mr. Justin Hunter as Lead Cultivators for the Company's EcoNevada and PhenoFarm Cultivation and Production licences in Las Vegas, Nevada.
A seasoned agriculturist, Mr. George has managed multiple large scale indoor, outdoor and off-grid cannabis cultivation facilities using a variety of techniques (hydroponics, soil and soilless mixtures) during his nine-year tenure in the cannabis industry.
Mr. George's comprehensive cannabis career has taken him around-the-world where he has attended numerous conferences and seminars to advance his knowledge of biology, genetics, and genotypes. More specifically, the effects of atmosphere, light cycles and nutrients in Desert, High Altitude and Northern climates. Additionally, he is an advocate of non-chemical pest management, and incorporates countermeasures such as employing companion plants and beneficial insects to prevent pests specific to cannabis. For the past several years, Mr. George has provided the highest quality medicinal cannabis to the medical community of Phoenix, Arizona.
Mr. Hunter, brings extensive experience in both commercial scale cannabis cultivation and management of facility operations. He has served as Director of Cultivation overseeing all aspects of facility management including the development of SOP's (the "Standard Operating Procedures") which are instrumental in providing elevated standards for all aspects of a heavily-regulated commercial production.
Mr. Hunter trained and managed teams of employees in effective commercialized methods of task completion, including overseeing crop management by strategizing perpetual harvest schedules, while monitoring the progress of crops for optimal quality, health and yield.
A principal focus of Mr. Hunter's career has been perfecting his "Pheno-hunting", a selective cannabis breeding technique used to ensure that "cream of the crop" genetics are passed along to future generations by breeding clone only strains to purebred males "hunted" for their vigor and potency. Mr. Hunter used his expertise in this field to champion our first genetics which will be transferred to their permanent location once all inspection approvals are granted.
As a team, they share a dedication to an organic living soil methodology which creates a higher quality, pure cannabis while reducing the cost of production. They are committed to the development of a triple organic certified product safe for consumption.
"Ryan and Justin have continually demonstrated their competency and passion for cannabis cultivation over the last decade. Their combined experience in commercial cannabis cultivation, including the selection of commercially viable varietals will bring an immediate impact to our bottom line. We look forward to having both Ryan and Justin lead the EcoNevada and PhenoFarm Cultivation programs." Kurt Keating, Director of Operations.
ABOUT MARAPHARM VENTURES INC.
www.marapharm.com
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
SOCIAL MEDIA:
Marapharm Ventures Inc. - Announces NV Energy Completes Transformer Installation For Permanent Power Ahead Of Schedule
KELOWNA, BC, May 3, 2018 /PRNewswire/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") is very pleased to announce that on Thursday April 26th, NV Energy crews arrived early on an expedited work order to launch the installation of our permanent Three Phase Transformer. NV Energy required complete control of the buildings and surrounding site to provide a safe transition from temporary to permanent power.
By late afternoon, NV Energy confirmed that the transformer was successfully connected energizing both buildings, passing multiple stress tests on the system. NV Energy will send a final crew this the week to configure and complete the installation of the electric meter, signifying to the State of Nevada that we are ready for the rescheduling of their follow-up building inspection. The Company holds three recreational cannabis licenses which are approved to operate within these buildings.
"We are ecstatic that NV Energy prioritized our installation several weeks earlier than originally anticipated! We thank NV Energy and their great staff for helping us move ahead of schedule in this regard." Corey Klassen, VP of Corporate Development.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
About Marijuana Stock Reporting.net
MarijuanaStockReporting.net is
a subsidiary
of Target Publishing Inc, and is a leading publisher of
todays market and investment news, commentary,
proprietary research and videos from seasoned
journalists, analysts and contributors covering the
financial markets and global economies. We have been
paid by a third party to wite this article Leveraging
our extensive distribution network and social media
presence, we have cultivated
a valuable audience of
engaged market enthusiasts, which in turn
delivers a variety of unique oppXortunities
for industry partnerships, corporate communications,
market exposure and investment. The
article does not constitute investment advice. Each
reader is encouraged to consult with his or her
individual financial professional and any action a
reader takes as a result of information presented here
is his or her own responsibility.
A complete disclaimer can be viewed HERE |
|
